(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADZENYS XR-ODT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ADZENYS XR-ODT

ST13

US500000086847760

Class

5

Filing

86847760

Registration

5147879

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

07/21/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

12/14/2015

Registration date

02/21/2017

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/01/2026

Last transaction

07/21/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/25/2016

First use in commerce

04/25/2016

Drawing code

4

Owner type

03

Owner location

Denver, CO, US

Examiner

YOUNG, CARRIE SKYE

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Neos Therapeutics, Inc.
Neos Therapeutics, Inc.

Representatives

Jake D. Siciliano

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Prescription pharmaceutical preparations for the treatment of disease and disorders of the central nervous systemexcluding pharmaceutical preparations for the prevention and treatment of disorders of the immune system; pharmaceutical preparations for the treatment of cancer; and pharmaceutical preparations for use in oncology

Publications

History of USPTO decisions and trademark events.

49 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/01/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/01/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/01/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/29/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

04/28/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/21/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/25/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/10/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/10/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/10/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/10/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/10/2023

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

09/27/2022

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

09/26/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/26/2022

ES8R

TEAS SECTION 8 RECEIVED

04/12/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/21/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/01/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/01/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/01/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/01/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/01/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/01/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/13/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/13/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

02/21/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/17/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/16/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/04/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/04/2017

IUAF

USE AMENDMENT FILED

12/08/2016

EISU

TEAS STATEMENT OF USE RECEIVED

12/08/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/02/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/07/2016

PUBO

PUBLISHED FOR OPPOSITION

06/07/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/18/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/29/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/21/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

04/21/2016

ALIE

ASSIGNED TO LIE

04/20/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/19/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

04/19/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/19/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/30/2016

GNRT

NON-FINAL ACTION E-MAILED

03/30/2016

CNRT

NON-FINAL ACTION WRITTEN

03/30/2016

DOCK

ASSIGNED TO EXAMINER

03/30/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/17/2015

NWAP

NEW APPLICATION ENTERED

12/17/2015

Continuous trademark protection

Get notified about every new filing that threatens ADZENYS XR-ODT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.